← Back to Search

Exoskeleton

Exoskeleton Training for Spinal Cord Injury (EXTra-SCI Trial)

Phase 2
Waitlist Available
Research Sponsored by McGuire Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Summary

This trial will help researchers understand how using an exoskeleton affects cardiovascular performance and body composition.

Eligible Conditions
  • Spinal Cord Injury

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Blood Pressure (mmHg)
Body Composition (kg)
Oxygen uptake (l/min)
+1 more
Secondary outcome measures
10 meter walk Test (m/sec)
Electromyography (EMG) activity of 6 muscle groups (mV)
Mitochondrial health using near infra-red spectroscopy (seconds)
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Exoskeleton TrainingExperimental Treatment1 Intervention
Twenty men with complete and incomplete SCI will be enrolled in the trial.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exoskeleton Training
2018
Completed Phase 2
~20

Find a Location

Who is running the clinical trial?

McGuire Research InstituteLead Sponsor
9 Previous Clinical Trials
361 Total Patients Enrolled
~3 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top